Inverse relation between Braak stage and cerebrovascular pathology in Alzheimer predominant dementia

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 5, 1999, Pages 654-657

  Goulding, Jonathan M R ^a   Signorini, David F ^b   Chatterjee, Sanjukta ^a   Nicoll, James A R ^c   Stewart, Janice ^c   Morris, Robert ^a   Lammie, G Alistair ^a,d  

^a Department of Pathology ^*  (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Cerebrovascular disease; Dementia

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0032849399     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.5.654     Document Type: Article

References (24)

1. Nagy Z, Esiri MM, Jobst KA, et al. The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 1997;56:165-70.
2. Holmes C, Cairns N, Lantos P, et al. Validity of the current clinical criteria for Alzheimer,s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999;174: 45-50.
3. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19:253-62.
4. Gold G, Giannakopoulos P, Bouras C. Reevaluating the role of vascular changes in the differential diagnosis of Alzheimer's disease and vascular dementia. European Neurology 1998;40:121-9.
5. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
6. Gertz H-J, Xuereb J, Huppert F, et al. Examination of the hierarchical model of neuropathological staging in normal aging and Alzheimer's disease. Acta Neuropathol 1998;95: 154-8.
7. Nicoll JAR, Burnett C, Love S, et al. High frequency of apolipoprotein E ε2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997;41:716-21.
8. Agresti A. An introduction to categorical data analysis. New York: Wiley, 1996:190-2.
9. Bowler JV, Munoz DG, Merskey H, et al. Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998;64:18-24.
10. Rezek DL, Morris JC, Fulling KH, et al. Periventricular white matter lucencies in senile dementia of Alzheimer type and in normal aging. Neurology 1987;37:1365-8.
11. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA 1997;277:813-17.
12. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, et al. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease. CERAD, part XVIII. Neurology 1998;51:159-62.
13. Brown DF, Dababo MA, Bigio EH, et al. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease. J Neuropathol Exp Neurol 1998;57:39-46.
14. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on dementia with Lewy bodies international workshop. Neurology 1996;47:1113-24.
15. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA 1997;278:1349-56.
16. Saunders AM, Strittmatter WI, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43: 1467-72
17. Poirier J, Davignon J, Bouthillier D, et al. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342: 697-9.
18. Strittmatter WI, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81.
19. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8: 1-21.
20. Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischaemic stroke. Role of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556-62.
21. Kosunen O, Talasniemi S, Lehtovirta M, et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995;26:743-8.
22. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-4.
23. Skoog I, Hesse C, Aevarsson O, et al. A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry 1998;64:37-43.
24. Kalaria RN, Cohen DL, Premkumar DRD. Apolipoprotein e alleles and brain vascular pathology in Alzheimer's disease. Ann NY Acad Sci 1996;777:266-70.